Analyzing the options chain and the chart patterns of UPS United Parcel Service prior to the earnings report this week, I would consider purchasing the $42.50 strike price Calls with an expiration date of 2023-8-18, for a premium of approximately $0.37. If these options prove to be profitable prior to the earnings release, I would sell at least half of...
Strategy Overview: The Frequency Formula Our trading strategy, "The Frequency Formula," is built on cutting-edge Fourier Wave Transform theory. The strategy utilizes four unique indicators: the Frequency Formula Chop Indicator (FF-CI), Frequency Formula Trend Indicator (FF-TI), the Frequency Formula Volume Indicator with Combined Ratios (FFVI-CR), and the...
Had a rough look at some Biotech stocks - looks like overall this sector is going to explode soon - I have no idea on fundamentals for this space but charts look damn good on a lot of these for multi month/year swing trades.
Might break downtrendline. Good build up before DTL BO.
Ionis Pharmaceuticals, Inc. ( NASDAQ:IONS ) Sector: Health Technology (Pharmaceuticals: Major) Current Price: $46.36 Breakout price trigger: $47.85 Buy Zone (Top/Bottom Range): $44.65-$39.75 Price Target: $55.50-$56.30 Estimated Duration to Target: 131-139d Contract of Interest: $IONS 1/20/23 50c Trade price as of publish date: $3.20/cnt
ions buy ..first target 34.57 ..finally target 39.00 ..stoploss 31.30
"George Lane identified another form of divergence to predict bottoms or tops, dubbed “set-ups.” A bull set-up is basically the inverse of a bullish divergence. The underlying security forms a lower high, but the Stochastic Oscillator forms a higher high. Even though the stock could not exceed its prior high, the higher high in the Stochastic Oscillator shows...
Down trend since January highs after 1st qtr company report. Overall price has dropped over 45%. Potential consolidation with trend reversal. This stock has been on my radar the last 2-3 weeks as I have been evaluating and looking for signs of a reversal before going long. Ratings/analysis are mixed for this stock. I believe there is substantial uncertainty...
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare...
Possible stop below C Possible T2/Long term/ 75.5 84 Not a recommendation
Hey my friends, IONIS PHARMACEUTICALS is between the middle and the top of the consolidation zone, large volume of sales probability of breaking it and going up may be next. Please LIKE & FOLLOW, thank you!
This is a Bullish indicator signaling IONS's price could rise from here. Traders may explore going long the stock or buying call options. I identified 40 similar cases where IONS's MACD histogram became positive, and 35 of them led to successful outcomes. Odds of Success: 88%.
Price action hook plus divergence suggest a retest of the $50-$54 region.
Hi Followers, Welcome to my page, I will be posting 10 charts on USA #STOCK #MARKET this month. #STOCKMARKET Using a Unique Technical Analysis invented by me. Later, if the charts work out, I will talk more about it. As far as our technical Analysis is identifying, there is a big possibility that this company is OVERBOUGHT, which opens a trade...
Spinning top candle RSI over bought Same run up after good earnings beat last quarter with the same result as this quarter Need one more correction before we can break above